World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jul. 01, 2025

Rank Company Market Cap (USD) Country Sector Industry
451 Biomm SA $174.6 M Brazil Brazilian Healthcare Brazilian Biotechnology
452 Avacta Group plc $172.9 M United Kingdom UK Healthcare UK Biotechnology
453 Dimerix Limited $172.2 M

(July 1, 2024)

 Australia Australian Healthcare Australian Biotechnology
454 Berkeley Lights, Inc. $168.7 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
455 Enanta Pharmaceuticals, Inc. $168.7 M United States US Healthcare US Biotechnology
456 TOT BIOPHARM International Company Ltd $168.1 M China Chinese Healthcare Chinese Biotechnology
457 Agenus Inc. $166.4 M United States US Healthcare US Biotechnology
458 Innate Pharma SA $166.1 M France French Healthcare French Biotechnology
459 4SC AG $164.5 M

(Feb. 1, 2023)

 Germany German Healthcare German Biotechnology
460 Mind Medicine MindMed, Inc. $164.0 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
461 Cellectis SA $163.2 M France French Healthcare French Biotechnology
462 Spero Therapeutics, Inc. $162.7 M United States US Healthcare US Biotechnology
463 Anika Therapeutics, Inc. $161.3 M United States US Healthcare US Biotechnology
464 DiaMedica Therapeutics Inc. $161.2 M United States US Healthcare US Biotechnology
465 Nanoform Finland Oyj $160.9 M

(July 1, 2024)

 Finland Finnish Healthcare Finnish Biotechnology
466 Japan Tissue Engineering Co. Ltd $160.9 M Japan Japanese Healthcare Japanese Biotechnology
467 Opthea Limited $160.7 M

(July 1, 2024)

 Australia Australian Healthcare Australian Biotechnology
468 Aclaris Therapeutics, Inc. $155.9 M United States US Healthcare US Biotechnology
469 La Jolla Pharmaceutical Company $155.1 M

(Aug. 1, 2022)

 United States US Healthcare US Biotechnology
470 JW $154.3 M China Chinese Healthcare Chinese Biotechnology
471 Alector, Inc. $151.0 M United States US Healthcare US Biotechnology
472 Energenesis Biomedical CO.,LTD. $149.3 M

(July 1, 2023)

 Taiwan Taiwanese Healthcare Taiwanese Biotechnology
473 Black Diamond Therapeutics, Inc. $146.7 M United States US Healthcare US Biotechnology
474 Cabaletta Bio, Inc. $146.6 M United States US Healthcare US Biotechnology
475 Checkpoint Therapeutics, Inc. $146.5 M

(Jan. 1, 2025)

 United States US Healthcare US Biotechnology
476 Medigen Biotechnology Corp $145.8 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
477 Xlife Sciences AG $145.1 M Switzerland Swiss Healthcare Swiss Biotechnology
478 Lyell Immunopharma, Inc. $143.5 M United States US Healthcare US Biotechnology
479 Inhibikase Therapeutics, Inc. $140.5 M United States US Healthcare US Biotechnology
480 Molecular Partners AG $139.9 M Switzerland Swiss Healthcare Swiss Biotechnology

Top Biotechnology Companies in the World as of Jul. 01, 2025

451. Biomm SA

Company Profile: Biomm SA
Market Cap (USD): $174.6 M
Country: Brazil
Sector: Brazilian Healthcare
Industry: Brazilian Biotechnology

452. Avacta Group plc

Company Profile: Avacta Group plc
Market Cap (USD): $172.9 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

453. Dimerix Limited

Company Profile: Dimerix Limited
Market Cap (USD): $172.2 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

454. Berkeley Lights, Inc.

Company Profile: Berkeley Lights, Inc.
Market Cap (USD): $168.7 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

455. Enanta Pharmaceuticals, Inc.

Company Profile: Enanta Pharmaceuticals, Inc.
Market Cap (USD): $168.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

456. TOT BIOPHARM International Company Ltd

Company Profile: TOT BIOPHARM International Company Ltd
Market Cap (USD): $168.1 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

457. Agenus Inc.

Company Profile: Agenus Inc.
Market Cap (USD): $166.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

458. Innate Pharma SA

Company Profile: Innate Pharma SA
Market Cap (USD): $166.1 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

459. 4SC AG

Company Profile: 4SC AG
Market Cap (USD): $164.5 M (Feb. 1, 2023)
Country: Germany
Sector: German Healthcare
Industry: German Biotechnology

460. Mind Medicine MindMed, Inc.

Company Profile: Mind Medicine MindMed, Inc.
Market Cap (USD): $164.0 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

461. Cellectis SA

Company Profile: Cellectis SA
Market Cap (USD): $163.2 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

462. Spero Therapeutics, Inc.

Company Profile: Spero Therapeutics, Inc.
Market Cap (USD): $162.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

463. Anika Therapeutics, Inc.

Company Profile: Anika Therapeutics, Inc.
Market Cap (USD): $161.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

464. DiaMedica Therapeutics Inc.

Company Profile: DiaMedica Therapeutics Inc.
Market Cap (USD): $161.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

465. Nanoform Finland Oyj

Company Profile: Nanoform Finland Oyj
Market Cap (USD): $160.9 M (July 1, 2024)
Country: Finland
Sector: Finnish Healthcare
Industry: Finnish Biotechnology

466. Japan Tissue Engineering Co. Ltd

Company Profile: Japan Tissue Engineering Co. Ltd
Market Cap (USD): $160.9 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

467. Opthea Limited

Company Profile: Opthea Limited
Market Cap (USD): $160.7 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

468. Aclaris Therapeutics, Inc.

Company Profile: Aclaris Therapeutics, Inc.
Market Cap (USD): $155.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

469. La Jolla Pharmaceutical Company

Company Profile: La Jolla Pharmaceutical Company
Market Cap (USD): $155.1 M (Aug. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

470. JW

Company Profile: JW
Market Cap (USD): $154.3 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

471. Alector, Inc.

Company Profile: Alector, Inc.
Market Cap (USD): $151.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

472. Energenesis Biomedical CO.,LTD.

Company Profile: Energenesis Biomedical CO.,LTD.
Market Cap (USD): $149.3 M (July 1, 2023)
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

473. Black Diamond Therapeutics, Inc.

Company Profile: Black Diamond Therapeutics, Inc.
Market Cap (USD): $146.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

474. Cabaletta Bio, Inc.

Company Profile: Cabaletta Bio, Inc.
Market Cap (USD): $146.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

475. Checkpoint Therapeutics, Inc.

Company Profile: Checkpoint Therapeutics, Inc.
Market Cap (USD): $146.5 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

476. Medigen Biotechnology Corp

Company Profile: Medigen Biotechnology Corp
Market Cap (USD): $145.8 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

477. Xlife Sciences AG

Company Profile: Xlife Sciences AG
Market Cap (USD): $145.1 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

478. Lyell Immunopharma, Inc.

Company Profile: Lyell Immunopharma, Inc.
Market Cap (USD): $143.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

479. Inhibikase Therapeutics, Inc.

Company Profile: Inhibikase Therapeutics, Inc.
Market Cap (USD): $140.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

480. Molecular Partners AG

Company Profile: Molecular Partners AG
Market Cap (USD): $139.9 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

Stay in touch